Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness

Background: Human papillomavirus (HPV) vaccination for young women up to age 26 is highly cost-effective and has been implemented in 65 countries globally. We investigate the cost-effectiveness for HPV vaccination program in older women (age > 26 years), heterosexual men and men who have sex with...

Full description

Saved in:

Bibliographic Details
Published in:	Human vaccines & immunotherapeutics Vol. 14; no. 12; pp. 3010 - 3018
Main Authors:	Soe, Nyi Nyi, Ong, Jason J., Ma, Xiaomeng, Fairley, Christopher K, Latt, Phyu Mon, Jing, Jun, Cheng, Feng, Zhang, Lei
Format:	Journal Article
Language:	English
Published:	United States Taylor & Francis 02-12-2018 Taylor & Francis Group
Subjects:	Adult Age Factors Cost-Benefit Analysis cost-effectiveness Databases, Factual Female Heterosexuality Homosexuality, Male Human papillomavirus Humans Immunization Programs Male men who have sex with men Papillomavirus Infections - economics Papillomavirus Infections - prevention & control Papillomavirus Vaccines - economics Review Sexual and Gender Minorities Uterine Cervical Neoplasms - economics Uterine Cervical Neoplasms - prevention & control Vaccination vaccine cost-effectiveness Human papillomavirus vaccine men who have sex with men
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!